Efficacy of and in the management of subclinical hypothyroidism: An open labelled randomized comparative pilot clinical trial.

Background: Subclinical hypothyroidism (SCH) is defined as a mildly reduced function of the thyroid gland having elevated serum thyroid-stimulating hormone (TSH) level and normal concentrations of free tri-iodothyronine (FT3), free tetra-iodothyronine (FT4), T3 and T4. It occurs due to (low metabolic activity) at the systemic and cellular level. and having its effect on (a root cause of SCH) are expected to prevent overt hypothyroidism and revert subclinical stage to euthyroid.

Clinical study of compound and lifestyle modification in management of metabolic syndrome: A double‑blind placebo controlled randomized clinical trial.

Background: Metabolic syndrome (MS) is a cluster of obesity, hypertriglyceridemia, impaired glucose tolerance, and insulin resistance. The sedentary lifestyle settles on the phenotypical expression of a genetically acquired trait in an obese person. Weight control and a healthy lifestyle remain primary and effective strategies for prevention and management of the MS.